Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
419 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 8 |
| 2012 | 10 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 16 |
| 2016 | 20 |
| 2017 | 29 |
| 2018 | 23 |
| 2019 | 27 |
| 2020 | 30 |
| 2021 | 38 |
| 2022 | 35 |
| 2023 | 19 |
| 2024 | 47 |
| 2025 | 37 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 102 |
| Completed | 93 |
| Unknown status | 64 |
| Terminated | 52 |
| Not yet recruiting | 47 |
| Active, not recruiting | 42 |
| Withdrawn | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 38 |
| M.D. Anderson Cancer Center | 13 |
| National Cancer Institute (NCI) | 12 |
| Sun Yat-sen University | 8 |
| Memorial Sloan Kettering Cancer Center | 7 |
| Chinese Academy of Medical Sciences | 6 |
| Tianjin Medical University Cancer Institute and Hospital | 6 |
| Dana-Farber Cancer Institute | 5 |
| MedSIR | 5 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 419 |
| Breast Neoplasms | 181 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Neoplasm Metastasis | 13 |
| Brain Neoplasms | 10 |
| Breast Neoplasms, Male | 8 |
| Inflammatory Breast Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Colorectal Neoplasms | 7 |
Trials
Showing 1 to 25 of 419. Each trial links to its page on Pharma Observatory.
319 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.